News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Goldman expects the Swiss franc to strengthen versus the euro as rising inflation reduces SNB intervention odds.
  • Goldman says the Canadian dollar has near-term support from the energy shock and should outperform many G10 peers.
  • Goldman warns the New Zealand dollar will stay pressured as the RBNZ adopts a dovish stance amid domestic slack.
  • SpaceX delays the Starship V3 test flight to May, postponing the debut by about four to six weeks.
  • SpaceX confidentially files for a U.S. IPO, eyeing a potential valuation above $1.75 trillion.

Latest Articles

ExlService Executive Disposes of $35.7K in Shares as Company Posts Q4 Beat

ExlService Executive Disposes of $35.7K in Shares as Company Posts Q4 Beat

Ajay Ayyappan, EVP and general counsel at ExlService Holdings, sold 1,197 shares on February 23, 2026, under a pre-arranged 10b5-1 plan. The company reported fourth-quarter 2025 results that exceeded analyst estimates for both EPS and revenue, while Needham trimmed its price target from $55.00 to $40.00 but kept a Buy rating, citing valuation compr…

Equillium: EQ504 Is the Hook — The Platform Could Be the Real Upside

Equillium: EQ504 Is the Hook — The Platform Could Be the Real Upside

Equillium is a clinical-stage biotech with a multi-cytokine pipeline anchored by EQ504 (AhR modulation for ulcerative colitis) and complementary assets (EQ001, EQ302). The stock trades around $1.83 with a market cap near $111M and roughly $10.7M in cash. Upcoming UC-focused KOL engagement, partnership work on an oral EQ302 formulation and improving…

Fastly CTO Sells $683K in Class A Stock Amid Strong Quarterly Results

Fastly CTO Sells $683K in Class A Stock Amid Strong Quarterly Results

Fastly Chief Technology Officer Artur Bergman sold 40,000 shares of Class A common stock on February 23, 2026, generating roughly $683,199. The disposition took place under a pre-established Rule 10b5-1 plan. The transaction occurred as Fastly’s shares have climbed markedly over the past year and the company posted a fourth-quarter beat that prompt…

Buy SentinelOne on the Dip - AI Endpoint Security at a Rare Discount

Buy SentinelOne on the Dip - AI Endpoint Security at a Rare Discount

SentinelOne (S) has been punished in 2025-26 despite clear market tailwinds for AI-powered endpoint protection. With a $4.39B market cap, positive free cash flow, and improving partner checks, the current price near $12.92 represents an asymmetric trade: meaningful upside if execution normalizes, limited downside to structural problems. This trade …

Nvidia Sees First-Quarter Revenue Above Street Forecast on Ongoing AI Spend

Nvidia Sees First-Quarter Revenue Above Street Forecast on Ongoing AI Spend

Nvidia forecast fiscal first-quarter sales that exceed analysts' expectations, citing sustained investment from large technology firms in artificial intelligence compute capacity. The chipmaker reported stronger-than-expected results for the January quarter, said it has licenses to ship limited quantities of a top AI chip to China, and signaled it …

Toronto market closes higher as S&P/TSX Composite hits fresh record

Toronto market closes higher as S&P/TSX Composite hits fresh record

Canadian equities finished higher on Wednesday, with the S&P/TSX Composite advancing 0.46% to reach a new all-time high. Strength in Financials, information technology and healthcare supported the market, while notable declines in several large-cap names limited broader upside. Volume breadth favored advancers, and volatility as measured by the S&P…

CrowdStrike: Buy the Panic — AI Fears Have Been Overblown

CrowdStrike: Buy the Panic — AI Fears Have Been Overblown

CrowdStrike (CRWD) has been punished disproportionately in the recent SaaS/AI rotation. The company's cloud-native platform, growing FCF, and positive channel checks make the current pullback a high-probability entry for a mid-term rebound. This trade recommends a long with a clear entry at $363.18, stop at $320.00 and a target of $460.00 over ~45 …

Rightmove: A Clear Entry as Sentiment Finally Reflects the Cycle

Rightmove: A Clear Entry as Sentiment Finally Reflects the Cycle

Rightmove’s dominance in UK property listings and a highly cash-generative model make it an attractive buy after a multi-quarter derating. With sale-facing revenue likely to recover with housing activity and limited capital intensity, a mid-term long trade at $7.50 targets a re-rating to $9.50, with a tight stop at $6.00 to protect against macro sh…

Draganfly: A High-Risk Long for Callable Upside in the Drone Patch

Draganfly: A High-Risk Long for Callable Upside in the Drone Patch

Draganfly is a microcap drone developer and services provider that could re-rate on a handful of wins: government or utility contracts, recurring service revenues, or a technology partnership. Public financial detail is limited, so this is a pure speculative trade that prioritizes risk control and position sizing. Enter small, expect volatility, an…